Karol Jelonek

916 citations
32 papers · 743 indexed · h-index 16

Karol Jelonek

32 papers receiving 732 citations

Peers

Karol Jelonek
Comparison fields: 5 of 81
  • Cancer Research 289
  • Molecular Biology 542
  • Radiology, Nuclear Medicine and Imaging 129
  • Otorhinolaryngology 23
  • Spectroscopy 69
Replace Chao‐Qun Hong with:
Chao‐Qun Hong China
Y. H. Fan China
Yunsong Li China
Carmen Lilla Germany
Vassilios Didilis Greece
O. John Semmes United States
Hongling Zhang China
Xiaofeng Li China
Ningyi Ma China
Karol Jelonek relative to Chao‐Qun Hong China Chao‐Qun Hong's profile →
Citations per field
00.5×5.8×
Chao‐Qun Hong · 1×
Citations per year

Countries citing papers authored by Karol Jelonek

Since Specialization
Citations

This map shows the geographic impact of Karol Jelonek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karol Jelonek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karol Jelonek more than expected).

Fields of papers citing papers by Karol Jelonek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karol Jelonek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karol Jelonek. The network helps show where Karol Jelonek may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Karol Jelonek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karol Jelonek Line = papers co-authored together Karol Jelonek links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20246
3 202310
4 20232
5 20234
6 20212
7 202013
8 201816
9 201811
10 201756
11 201754
12 201714
13 201721
14 2016113
15 201614
16 201532
17 201524
18 20146
19 201311
20 201099

About Karol Jelonek

Karol Jelonek is a scholar working on Otorhinolaryngology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 32 papers that have together received 743 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (11 papers), Effects of Radiation Exposure (9 papers), Cancer, Lipids, and Metabolism (8 papers), Advanced Proteomics Techniques and Applications (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Extracellular vesicles in disease (4 papers), Mitochondrial Function and Pathology (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (289 citations), Molecular Biology (542 citations) and Radiology, Nuclear Medicine and Imaging (129 citations). Karol Jelonek has collaborated with scholars based in Poland, United Kingdom and Germany. Frequent co-authors include Piotr Wiland, Monika Pietrowska, Joanna Polańska, Łukasz Marczak, Anna Wojakowska, Agnieszka Gdowicz‐Kłosok, Magdalena Borkowska, Joanna Rzeszowska‐Wolny, Małgorzata Łysek-Gładysińska and Dorota Gabryś. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026